Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ (2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in idiopathic intracranial hypertension
With Hers new GLP1 weight loss program, those potential benefits may now be within reach for more people than ever before
Attention has centered on glucagon-like peptide-1 receptor agonists (GLP-1s)originally developed for type 2 diabetesyet now emerging as highly effective options in managing obesity
Are pills you can tote around best for you, gummies you dont need to grab a drink to consume, or powders you can mix in a drink